All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Novo Nordisk A/S revenue reports

Novo Nordisk A/S financial reports, Novo Nordisk A/S annual revenue in 2024. When does Novo Nordisk A/S report revenue?
Add to widgets
Added to widgets

Novo Nordisk A/S total revenue, net income and dynamics of changes in Mexican peso today

Net revenue of Novo Nordisk A/S on 31/03/2021 amounted to 33 804 000 000 $. Net income of Novo Nordisk A/S today amounted to 12 623 000 000 $. Here are the main financial indicators of Novo Nordisk A/S. The financial graph of Novo Nordisk A/S shows the values and changes of such indicators: total assets, net income, net revenue. The financial report schedule from 31/03/2019 to 31/03/2021 is available online. The value of all Novo Nordisk A/S assets on the graph is shown in green.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 559 547 470 800 $ +15.41 % ↑ 208 944 732 100 $ +20.85 % ↑
31/12/2020 531 970 672 600 $ -0.861 % ↓ 154 238 058 600 $ +6.89 % ↑
30/09/2020 511 925 352 900 $ +2.15 % ↑ 170 459 704 600 $ +1.02 % ↑
30/06/2020 496 680 316 200 $ -0.0999 % ↓ 175 872 437 500 $ +10.73 % ↑
31/12/2019 536 588 875 900 $ - 144 289 885 900 $ -
30/09/2019 501 166 097 900 $ - 168 738 223 800 $ -
30/06/2019 497 176 897 200 $ - 158 823 156 500 $ -
31/03/2019 484 845 135 700 $ - 172 892 951 500 $ -
Show:
to

Novo Nordisk A/S financial report charts

The dates of the latest financial statements of Novo Nordisk A/S: 31/03/2019, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Novo Nordisk A/S is 31/03/2021. Gross profit Novo Nordisk A/S is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Novo Nordisk A/S is 27 993 000 000 $

Novo Nordisk A/S quarterly report dates

Cost of revenue Novo Nordisk A/S is the total cost of producing and distributing of products and services of a company. Cost of revenue Novo Nordisk A/S is 5 811 000 000 $ Total revenue Novo Nordisk A/S refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Novo Nordisk A/S is 33 804 000 000 $ Operating income Novo Nordisk A/S is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Novo Nordisk A/S is 14 982 000 000 $

Net income Novo Nordisk A/S is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Novo Nordisk A/S is 12 623 000 000 $ Current assets Novo Nordisk A/S is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Novo Nordisk A/S is 61 389 000 000 $ Total assets Novo Nordisk A/S refers to the total amount of assets owned by a person or entity. Total assets Novo Nordisk A/S is 141 387 000 000 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
463 359 731 100 $ 438 961 051 300 $ 426 596 184 400 $ 417 690 831 800 $ 455 430 987 800 $ 417 161 145 400 $ 416 912 854 900 $ 406 517 759 300 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
96 187 739 700 $ 93 009 621 300 $ 85 329 168 500 $ 78 989 484 400 $ 81 157 888 100 $ 84 004 952 500 $ 80 264 042 300 $ 78 327 376 400 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
559 547 470 800 $ 531 970 672 600 $ 511 925 352 900 $ 496 680 316 200 $ 536 588 875 900 $ 501 166 097 900 $ 497 176 897 200 $ 484 845 135 700 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
247 992 551 400 $ 190 819 525 600 $ 212 006 981 600 $ 229 056 262 600 $ 212 735 300 400 $ 213 844 331 300 $ 222 666 920 400 $ 235 693 895 300 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
208 944 732 100 $ 154 238 058 600 $ 170 459 704 600 $ 175 872 437 500 $ 144 289 885 900 $ 168 738 223 800 $ 158 823 156 500 $ 172 892 951 500 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
65 283 848 800 $ 68 412 309 100 $ 64 737 609 700 $ 54 474 935 700 $ 65 118 321 800 $ 59 606 272 700 $ 58 877 953 900 $ 44 328 130 600 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
311 554 919 400 $ 341 151 147 000 $ 299 918 371 300 $ 267 624 053 600 $ 323 853 575 500 $ 287 321 766 600 $ 274 509 976 800 $ 249 151 240 400 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
1 016 153 700 300 $ 1 089 316 634 300 $ 1 219 387 750 900 $ 1 217 931 113 300 $ 1 033 815 431 200 $ 1 049 441 180 000 $ 971 974 544 000 $ 872 890 081 800 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
2 340 336 594 900 $ 2 398 850 389 400 $ 2 316 500 706 900 $ 2 253 170 076 700 $ 2 079 217 752 400 $ 2 067 564 651 600 $ 1 951 712 304 300 $ 1 823 031 614 500 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
94 068 994 100 $ 211 162 793 900 $ 421 762 796 000 $ 411 731 859 800 $ 256 153 032 500 $ 310 478 993 900 $ 239 302 383 900 $ 149 884 698 500 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 976 327 904 100 $ 1 044 260 184 900 $ 936 800 056 500 $ 906 425 852 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 1 125 898 101 300 $ 1 191 049 528 500 $ 1 073 012 224 800 $ 1 039 774 403 200 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 54.15 % 57.61 % 54.98 % 57.04 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
968 266 739 200 $ 1 048 199 727 500 $ 986 093 997 100 $ 994 055 845 800 $ 953 319 651 100 $ 876 515 123 100 $ 878 700 079 500 $ 783 257 211 300 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 85 494 695 500 $ 276 231 457 600 $ 248 936 055 300 $ 163 706 203 000 $

Last revenue report of Novo Nordisk A/S was 31/03/2021. According to last financial report total revenue in Novo Nordisk A/S was 559 547 470 800 Mexican peso and changed by +15.41% since last year. Net income in Novo Nordisk A/S was 208 944 732 100 $ in last quartal, net income changes to +20.85%.

Current cash Novo Nordisk A/S - the sum of all of the cash a company has on the date of report. Current cash Novo Nordisk A/S is 5 683 000 000 $

Novo Nordisk A/S stocks data

Novo Nordisk A/S financials